Details for New Drug Application (NDA): 018536
✉ Email this page to a colleague
NDA 018536 describes XENON XE 127, which is a drug marketed by Mallinckrodt and is included in one NDA. Additional details are available on the XENON XE 127 profile page.
The generic ingredient in XENON XE 127 is xenon xe-127. There are twelve drug master file entries for this compound. Additional details are available on the xenon xe-127 profile page.
The generic ingredient in XENON XE 127 is xenon xe-127. There are twelve drug master file entries for this compound. Additional details are available on the xenon xe-127 profile page.
Summary for 018536
| Tradename: | XENON XE 127 |
| Applicant: | Mallinckrodt |
| Ingredient: | xenon xe-127 |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | GAS;INHALATION | Strength | 5mCi/VIAL | ||||
| Approval Date: | Oct 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | GAS;INHALATION | Strength | 10mCi/VIAL | ||||
| Approval Date: | Oct 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
